Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes

Tristan Richardson1, Adrian Rozkovec, Peter Thomas

  • 1Bournemouth Diabetes & Endocrine Centre, Royal Bournemouth Hospital, Bournemouth, UK. tristan.richardson@rbch-tr.swest.nhs.uk

Diabetes Care
|April 28, 2004
PubMed

Insights

Caffeine consumption significantly improved heart rate variability (HRV), a measure of autonomic function, in both type 1 diabetes patients and healthy individuals. This suggests caffeine may help reduce cardiovascular event risk in those with impaired autonomic function.

Area of Science:

  • Cardiovascular Health
  • Autonomic Function
  • Diabetes Research

Background:

  • Cardiovascular health effects of caffeine are debated.
  • Type 1 diabetes patients with autonomic failure face risks like sudden cardiac death.
  • Autonomic dysfunction, assessed via heart rate variability (HRV), is a concern in this population.

Purpose of the Study:

  • To investigate caffeine's impact on autonomic dysfunction in type 1 diabetes patients.
  • To compare caffeine's effects on HRV in diabetic patients versus healthy controls.

Main Methods:

  • Randomized, blinded, placebo-controlled, crossover trial.
  • 20 type 1 diabetic patients and 10 healthy volunteers participated.
  • Caffeine (250 mg twice daily) or placebo was administered for 2 weeks.

Main Results:

  • Diabetic patients exhibited blunted baseline HRV compared to controls (P < 0.0005).
  • Caffeine markedly increased HRV in both groups: +103% in diabetics (P = 0.009) and +38% in controls (P = 0.002).
  • The increase in HRV due to caffeine did not differ significantly between groups (P = 0.16).

Conclusions:

  • Moderate caffeine intake enhances autonomic function in both diabetic patients and healthy individuals.
  • Regular caffeine use could potentially mitigate cardiovascular event risk in those with abnormal HRV.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...